We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+13.5%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$21.9B
AUM Growth
+$430M
Cap. Flow
-$2.03B
Cap. Flow %
-9.27%
Top 10 Hldgs %
51.69%
Holding
190
New
27
Increased
30
Reduced
39
Closed
32

Top Buys

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$731M
2
HES
Hess
HES
+$436M
3
NDAQ icon
Nasdaq
NDAQ
+$341M
4
SPLK
Splunk Inc
SPLK
+$157M
5
UTHR icon
United Therapeutics
UTHR
+$110M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.9B
2
VMW
VMware, Inc
VMW
+$915M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$770M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$482M
5
AON icon
Aon
AON
+$216M

Sector Composition

Rank Sector Weight
1 Healthcare 27.49%
2 Technology 11.1%
3 Financials 9.67%
4 Industrials 6.16%
5 Communication Services 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LBPH
76
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$9.41M 0.04%
1,560,500
– –
SOVO
77
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
$9.21M 0.04%
+418,000
New +$9.19M
CZOO
78
DELISTED
Cazoo Group Ltd
CZOO
$6.79M 0.03%
+714,240
New +$24.6M
SLNO
79
DELISTED
Soleno Therapeutics
SLNO
$6.65M 0.03%
165,219
-222,781
-57% -$6.34M
HCA icon
80
HCA Healthcare
HCA
$89.5B
$5.66M 0.03%
20,900
-153,500
-88% -$37.9M
GOSS icon
81
Gossamer Bio
GOSS
$87M
$5.59M 0.03%
6,130,272
– –
GHIX
82
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
$5.25M 0.02%
500,000
– –
VNET
83
VNET Group
VNET
$2.09B
$5.09M 0.02%
1,775,000
– –
QTRX icon
84
Quanterix
QTRX
$190M
$5.03M 0.02%
+184,000
New +$4.33M
IOVA icon
85
Iovance Biotherapeutics
IOVA
$2.87B
$4.57M 0.02%
+562,000
New +$2.94M
CRNX icon
86
Crinetics Pharmaceuticals
CRNX
$8.92B
$4.37M 0.02%
122,904
-239,000
-66% -$7.33M
IVCP
87
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$3.23M 0.01%
300,000
– –
BACA
88
DELISTED
Berenson Acquisition Corp. I
BACA
$2.93M 0.01%
285,715
– –
BLUE
89
DELISTED
bluebird bio
BLUE
$2.76M 0.01%
+100,000
New +$6.1M
ARYD
90
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$2.18M 0.01%
200,000
– –
MTAL
91
DELISTED
Metals Acquisition
MTAL
$1.95M 0.01%
157,500
– –
GATE
92
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$1.56M 0.01%
150,000
– –
FBRX icon
93
Forte Biosciences
FBRX
$1.57B
$1.49M 0.01%
72,418
– –
MTAL.WS
94
DELISTED
Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share
MTAL.WS
$1.41M 0.01%
825,000
– –
TVRD
95
Tvardi Therapeutics
TVRD
$23.4M
$1.16M 0.01%
43,229
-3,065
-7% -$127K
SMC
96
Summit Midstream
SMC
$419M
$1.04M ﹤0.01%
58,214
– –
GRND.WS
97
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$977K ﹤0.01%
540,000
– –
EDU icon
98
New Oriental
EDU
$8.98B
$953K ﹤0.01%
13,000
– –
SAGE
99
DELISTED
Sage Therapeutics
SAGE
$927K ﹤0.01%
42,800
– –
MDGL icon
100
Madrigal Pharmaceuticals
MDGL
$11.8B
$768K ﹤0.01%
3,319
– –
2 3
4
5 6

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Farallon Capital Management held 190 positions worth $21.9B, up 2% from $21.4B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Farallon Capital Management withdrew a net $2.03B in Q4 2023, closing 32 positions and reducing 39 holdings. Its most notable exit was Activision Blizzard, an estimated $1.9B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Pioneer Natural Resource Co. worth $702M.

  • Farallon Capital Management's largest Q4 2023 buy was Pioneer Natural Resource Co.: 3,120,000 shares worth $702M.
  • Farallon Capital Management added most to Nasdaq in Q4 2023, an estimated $341M increase.
  • Farallon Capital Management's biggest Q4 2023 reduction was AstraZeneca, cutting an estimated $145M.
  • Farallon Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $1.9B.
  • Farallon Capital Management's ten largest holdings make up 52% of its $21.9B portfolio in Q4 2023.
  • Farallon Capital Management opened 27 new positions and closed 32 in Q4 2023.
  • Farallon Capital Management's portfolio value rose 2% quarter-over-quarter to $21.9B.

Based on Farallon Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.